SCHEMBL2562045

SCHEMBL2562045

CCOC(=O)Oc1nc(NC(=O)Nc2ccc(C)c(F)c2)cn1C

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.49
RAB9A P51151 3/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
KDM4E B2RXH2 1/20 0.49
TSHR P16473 2/20 0.45
ALDH1A1 P00352 2/20 0.45
DHODH Q02127 4/20 0.44
LMNA P02545 3/20 0.43
MAPT P10636 4/20 0.43
TP53 P04637 2/20 0.43
FPR2 P25090 2/20 0.42
MAPK1 P28482 1/20 0.41
MEN1 O00255 1/20 0.40
HTT P42858 1/20 0.40
KMT2A Q03164 1/20 0.40
NTRK1 P04629 1/20 0.40
NTRK2 Q16620 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2569997 0.87 MAPT (0.48) NPC1RAB9ASMN1; SMN2KDM4EALDH1A1
SCHEMBL2881471 0.85 NPC1 (0.53) NPC1RAB9ASMN1; SMN2KDM4ETSHR
SCHEMBL2568013 0.82 EPHX2 (0.52) NPC1RAB9ASMN1; SMN2ALDH1A1LMNA
SCHEMBL2569996 0.77 MAPT (0.50) NPC1RAB9ASMN1; SMN2ALDH1A1LMNA
SCHEMBL4110966 0.73 MAPT (0.72) NPC1RAB9ASMN1; SMN2KDM4ETSHR
SCHEMBL4118553 0.71 NPC1 (0.69) NPC1RAB9ASMN1; SMN2ALDH1A1LMNA
SCHEMBL13695917 0.70 MAPT (0.68) NPC1RAB9ASMN1; SMN2TSHRALDH1A1
SCHEMBL4116098 0.70 RAB9A (0.57) NPC1RAB9ASMN1; SMN2ALDH1A1LMNA
SCHEMBL8251624 0.69 SMN1; SMN2 (0.58) NPC1RAB9ASMN1; SMN2KDM4ETSHR
SCHEMBL4118206 0.69 MAPT (0.67) NPC1RAB9ASMN1; SMN2ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1732901-B1 ANTIVIRAL 4-AMINOCARBONYLAMINO-SUBSTITUTED IMIDAZOLE COMPOUND AICURIS GMBH & CO KG (DE) 2011-11-02 EP disclosed
EP-1732901-A1 ANTIVIRAL 4-AMINOCARBONYLAMINO-SUBSTITUTED IMIDAZOLE COMPOUND Bayer HealthCare AG (DE) 2006-12-20 EP disclosed
WO-2005092865-A1 ANTIVIRAL 4-AMINOCARBONYLAMINO-SUBSTITUTED IMIDAZOLE COMPOUND BAYER HEALTHCARE AG (DE) 2005-10-06 WO disclosed